Kentucky Trust Co Makes New $41,000 Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Kentucky Trust Co bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 522 shares of the company’s stock, valued at approximately $41,000.

Other hedge funds also recently bought and sold shares of the company. LGT Financial Advisors LLC increased its position in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Capital Performance Advisors LLP acquired a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Darwin Wealth Management LLC acquired a new position in GE HealthCare Technologies in the 3rd quarter worth about $31,000. Finally, Continuum Advisory LLC increased its position in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on GEHC shares. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $96.77.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $85.90 on Thursday. The business has a 50 day moving average price of $83.58 and a 200 day moving average price of $85.39. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.55. The company has a market cap of $39.25 billion, a price-to-earnings ratio of 23.60, a PEG ratio of 2.93 and a beta of 1.15. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a dividend of $0.035 per share. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.